Search Results 931-940 of 19796 for Receptor
... receptor blockers (ARBs), and/or aldosterone antagonists, without change in dose for at least 1 month before study intervention; The patient is on a stable ...
These approaches look like they will be good partners with immune checkpoint and chimeric antigen receptor (CAR)-T cell therapies by firing up the immune ...
The PROMISE of Cell-Free DNA Signatures To Predict Resistance to Palbociclib Plus Endocrine Therapy in Hormone Receptor (HR)-Positive, HER2-Negative, Advanced ...
... receptor signaling inhibitors (ARSIs), is often lethal. Approximately one-third of patients with mCRPC develop lethal resistant disease. Seeking answers on ...
... receptor status, and line of therapy. Subjects will continue protocol directed therapy until documentation of disease progression, development of ...
... receptor 1 (HER1) (epidermal growth factor receptor [EGFR]) pathway; Prior therapy with trastuzumab; Prior allergic reaction to the study drugs involved in ...
Patients with known EGFR (Epidermal growth factor receptor) tyrosine kinase (TK) activating mutations and anaplastic lymphoma kinase (ALK) rearrangements ...
At the same time, the therapeutic response to those agents varies. For example, aromatase inhibitors used to treat hormonal receptor-positive breast cancer — ...
receptors (eg, 4-1BB, OX40) - Cohort B only: - Known history of Grade 3 or higher immune-related adverse events (irAEs) that led to treatment ...
Lacy BE, Cangemi DJ. Opioids and the Gastrointestinal Tract: The Role of Peripherally Active micro-Opioid Receptor Antagonists in Modulating Intestinal ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.